Skip to main content
Premium Trial:

Request an Annual Quote

John Roberts Dies

John Roberts, a Caltech organic chemist, has died, the New York Times reports. He was 98.

In the 1950s, Roberts made the use of nuclear magnetic resonance spectroscopy to study chemical structures and reactions more popular, the Times says. "This was a real revolution for organic chemists at the time," Caltech's Peter Dervan tells the Times. "Jack saw the potential use of this spectroscopy and mastered it, and then, by publishing papers in this area, convinced other organic chemists that this was a powerful tool."

Roberts also paved the way for the more common use of isotopes as tracer molecules and, in the late 1940s while at MIT, he conducted an experiment that produced benzyne, confirming that this version of benzene with a triple bond did exist.

However, the Times notes that he has said that "best thing" he did at Caltech was to insist when he was offered a position there in 1953 that the school let his graduate student Dorothy Semenow in, at a time when Caltech did not admit women.

"He spearheaded the campaign to get Caltech to admit women," Semenow tells the Times. "He and Linus Pauling were very courageous in doing that."

Filed under

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.